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AbsTrACT
background Evidence suggests that social protection 
policies such as Brazil’s Bolsa Família Programme (BFP), 
a governmental conditional cash transfer, may play a role 
in tuberculosis (TB) elimination. However, study limitations 
hamper conclusions. This paper uses a quasi-experimental 
approach to more rigorously evaluate the effect of BFP on 
TB treatment success rate.
Methods Propensity scores were estimated from a 
complete-case logistic regression using covariates from a 
linked data set, including the Brazil’s TB notification system 
(SINAN), linked to the national registry of those in poverty 
(CadUnico) and the BFP payroll.
results The average effect of treatment on the treated 
was estimated as the difference in TB treatment success 
rate between matched groups (ie, the control and exposed 
patients, n=2167). Patients with TB receiving BFP showed 
a treatment success rate of 10.58 percentage points 
higher (95% CI 4.39 to 16.77) than patients with TB not 
receiving BFP. This association was robust to sensitivity 
analyses.
Conclusions This study further confirms a positive 
relationship between the provision of conditional cash 
transfers and TB treatment success rate. Further research 
is needed to understand how to enhance access to social 
protection so to optimise public health impact.
InTroduCTIon
Despite biomedical efforts, the global burden 
of tuberculosis (TB) remains consider-
able, with up to 1.5 million deaths from TB 
recorded in 2015.1 TB treatment takes many 
months, and a proportion of patients are not 
cured, either because they abandon treat-
ment, take treatment irregularly, are infected 
with drug-resistant TB, or die before comple-
tion of treatment.1 The correlation between 
TB indicators and global poverty has been 
demonstrated both at ecological and indi-
vidual levels, yet much of the morbidity and 
mortality in patients with TB still occur among 
the poorest segments of the population.2 
Social determinants impact vulnerability to 
TB at every stage of the disease pathway, from 
TB infection to clinical outcomes, including 
whether or not the patient was successfully 
treated.3 Ending the global burden of TB 
requires bold policies and supportive systems 
able to recognise and tackle these social 
determinants.4
Recognising this social aspect of TB epide-
miology, social protection is now a non-nego-
tiable component to reach the TB elimination 
targets set by the WHO, including zero house-
holds affected by catastrophic costs, defined 
as TB-related expenditures when they exceed 
20% of preillness annual household income.5 
Key questions
What is already known?
 ► While encouraging, evidence about the impact of 
cash transfers on tuberculosis (TB) control is still 
scattered and conclusions are often hampered by 
important study limitations.
What are the new findings?
 ► This is the first study using a quasi-experimental 
design to evaluate the impact of Bolsa Familia on TB 
treatment success.
 ► Patients with TB enrolled in Bolsa Familia are more 
likely to complete their treatment successfully.
 ► Approximately half of patients with TB included in 
this study population were not enrolled in the cash 
transfer programme despite being eligible based on 
the income inclusion criterion.
What do the new findings imply?
 ► Conditional cash transfers like Bolsa Familia can 
contribute to TB elimination even if they were not 
designed for this purpose.
 ► Disparity in access is a missed opportunity to maxi-
mise TB impact of Bolsa Familia.
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Brazil in particular has been an early adopter of the 
WHO’s End TB Strategy,6 as reflected by its long-term 
efforts to integrate development and health agendas. 
This is partially due to the long social protection tradition 
in Latin America, which in Brazil culminated with the 
creation of the Bolsa Família Programme (BFP) in 2003, 
one of the largest conditional cash transfer programmes 
in the world.7
In 2010, the BFP provided a variable monthly stipend 
to households meeting certain socioeconomic criteria: 
households earning less than R$70 a month (~US$22 at 
time of writing) and households with children, adoles-
cents or pregnant women earning less than R$ ‎140 a 
month. BFP’s targeting is not exact, and individuals 
reporting an income above R$ ‎140 can be found in the 
BFP payroll.7 In order to receive BFP, families must 
be registered in the Cadastro Unico (single registry; 
CadÚnico), a registry of all low-income Brazilian 
families. In return for the transfers, recipients must 
comply with behavioural obligations (ie, school atten-
dance; immunisation). BFP is not explicitly intended 
to target TB-affected households and only one-fourth 
of patients with TB in Brazil appear to be enrolled in 
the programme; given the intimate association between 
poverty and TB, underenrolment is likely.8 Despite 
accumulating, the literature on the impact of condi-
tional cash transfers on a variety of TB indicators is 
still limited, and there has been little methodologically 
rigorous evaluation of social protection interventions 
for TB prevention, care and control, including treat-
ment outcomes.9 There has also been some support 
in the literature for financial incentives having a small 
positive effect on TB outcomes,10 but the underlying 
philosophy, mechanisms of action, as well as the ethical 
and sustainability implications for financial incentives 
may differ from cash transfers embedded into proper 
governmental social protection platforms.11
Despite its scarcity, the evidence is converging on a 
consistent positive impact of social protection on TB 
epidemiology and control, including some small-scale 
trials and studies in Peru,12 Moldova13 and South Afri-
ca.14–16As for Brazil, the literature is even more rich 
even if evidence does not necessarily follow from proper 
controlled trials.15–18 Torrens et al8 have already attempted 
to estimate the impact of BFP on TB treatment success 
rates and found out that patients with TB enrolled in BFP 
were approximately 7% more likely to be successfully 
treated after treatment than a control group.8 While the 
findings of this study are consistent with what observed in 
the literature, conclusions are hampered by the potential 
biased nature of the control group.8
For an unbiased estimate of the proportion of patients 
cured attributable to BFP, we must construct a control 
group as similar as possible to the group of BFP recipi-
ents. This group of BFP recipients on average have some 
TB treatment success rate. We wish to estimate the differ-
ence in that treatment success rate if, counter to fact, that 
group of patients had not received BFP, but had the same 
sociodemographic characteristics and were thus still 
enrolled in CadÚnico.
To this aim, we approach the same routine data source 
as in Torrens et al8 using a quasi-experimental approach 
to construct a more appropriate control group and to 
then determine a more rigorous estimate of the effect 
of BFP on TB treatment success rate among those who 
receive it. Specifically, we aimed to: (1) use propensity 
score matching to create a control group balanced for 
propensity to receive BFP, (2) provide an estimate of the 
average treatment effect of BFP on TB treatment success 
rate among recipients and (3) to reflect on the utility of 
the resulting estimate for changing TB policy.
MeTHods
Conceptual framework: directed acyclic graph
A directed acyclic graph (DAG) was proposed for 
conceiving of the causal relationships between the 
outcome, the exposure and all the variables hypothesised 
to be on the causal pathway (figure 1). Each node in 
the DAG consists of a high-level construct measured by 
proxy variables taken from the set of covariates available 
(table 1). The nodes in this DAG were constructed based 
on a variety of theoretical literature, and the grouping of 
covariates under one node denotes that they are consid-
ered to be measures of that underlying construct for 
the purposes of this paper.3 19 20 Online supplementary 
appendix 1 outlines explicitly which covariates fall under 
each node.
The DAG outlines potential mechanisms by which BFP 
(‘the exposure’) is proposed to affect treatment success 
rate (‘the outcome’). These include via access to directly 
observed treatment and via increased capacity for mitiga-
tion of catastrophic costs (expenditure). We provide an 
estimate for the direct effect of social protection outside 
of these pathways, which may include expanded access to 
healthcare through means other than Directly Observed 
Therapy (DOT), increased psychological well-being or 
greater integration into governmental systems in general. 
The DAG also outlines pathways between treatment 
success rate and income (and therefore access to BFP), 
through complex relationships between demographics, 
geography and socioeconomic factors. The ‘treatment 
success’ outcome includes those who completed treat-
ment with or without bacteriological confirmation.
data handling
The data for this study arose from a linkage between the 
2010 TB data set from SINAN (Brazil's national Notifiable 
Disease Surveillance System) and the 2011 CadÚnico 
data set. The CadÚnico data set was itself linked to the 
Bolsa Familia payroll held by the Caixa Federal (Federal 
Bank). The linkage added the demographic and social 
information from CadÚnico and the BFP payroll to every 
patient with TB in the SINAN data set.
Of the complete SINAN-CadÚnico-BFP data set (n=180 
046), only individuals who were new TB cases registered in 
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Figure 1 Directed acyclic graph (DAG) outlining the pathways linking Bolsa Familia with tuberculosis (TB) outcomes. A DAG 
was built to conceptualise the potentially causal relationships between constructs relevant for measuring the impact of Bolsa 
Familia on TB treatment success rate. Red nodes are ancestors of both the outcome and the exposure (ie, confounders) while 
grey nodes are unassociated with the outcome and exposure. Blue nodes are ancestors of the outcome. The DAG links nodes 
that represent constructs that are measured by covariates table 2).
CadUnico in 2010 with a non-missing treatment outcome 
variable were retained for this study (n=16 760). Exposed 
individuals (defined here as those receiving BFP) were 
further restricted to those whose receipt of BFP preceded 
case closure. Case closure is defined as the date on which 
an outcome (eg, treated, unsuccessful completion of 
treatment, death) is recorded. The final data set used 
for analysis included 13 029 individuals, 6940 of whom 
received BFP. The data set contained a set of 60 covari-
ates that could be used for propensity score matching (ie, 
categorical or numerical data).
Many of these 60 covariates had a considerable amount 
of missing data. Data were assumed to be missing 
completely at random. Variables that were recorded 
as missing in over 50% of individuals were omitted 
from the analysis. These variables included house type 
(permanent/improvised), roof, floor, and wall material, 
number of people and families in the home, number of 
bedrooms and bathrooms, variables relating to employ-
ment status, expenditure on rent and transport, and 
receipt of pension, unemployment benefit and alimony. 
It is conceivable that rent and transport expenditure 
could be important confounders of treatment success 
rate given the potential of cash transfers for mitigating 
catastrophic costs, but neither are conditionally associ-
ated with both outcome and exposure in the observed 
data and expenditure is represented by other retained 
variables.21
The omission of variables with this level of missing 
data resulted in 45 covariates to be considered for use in 
propensity score estimation. A sensitivity analysis was run 
omitting all variables with over 25% missing data, which 
further omitted water expenditure and years of formal 
education. At both missing data thresholds, at least one 
proxy covariate remained under each node of the DAG 
such that no high-level construct was unrepresented by 
the available covariates.
Propensity score matching
Without applying propensity score approaches or other 
approaches to control for confounding, it is likely 
that the values of the available covariates between the 
exposed and the unexposed (and those who experience 
or do not experience the outcome) vary, which poten-
tially biases comparisons between groups. We wish to 
achieve a ‘balance’ in these values, which may approx-
imate the balance produced by conventional randomi-
sation procedures. We wish to first determine the likeli-
hood of receiving BFP given the covariate values, which 
is represented by the propensity score. If the propensity 
score is then balanced between groups by matching, it is 
as though the covariates that were used to estimate the 
propensity score were themselves balanced.22
Propensity scores were estimated by logistic regres-
sion. One of two criteria must be met for a variable to 
be included in this logistic regression: (A) conditional 
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Table 1 Variables to operationalise constructs included in the statistical models
Node (construct) Covariates included in the model
Covariates excluded 
from the model 
(missing data 
threshold)
Covariates excluded 
from the model (no 
available measure)
State State
Race Race, indigenous, quilombola
Local area Urbanicity, running water, sewage, electricity, 
water store, garbage collection
House type Transit access
Education Years of education, literacy
Socioeconomic 
vulnerability
Child work, institutionalisation, work-acquired TB Employment, pension 
receipt, unemployment 
benefit, alimony receipt
Food security, adequate 
nutrition, perception of 
poverty
Age and sex Age, sex Gender identity
Comorbidities AIDS, alcohol use disorder, diabetes, HIV, mental 
disorder, other chronic illness
General mental health, 
stress
Income Income
Expenditure (on) Food, energy, gas, water (on) Rent, transport Medical costs
Health-seeking 
behaviour
Directly observed treatment Engagement with primary 
care
TB form and severity Chest X-ray, initial sputum smear, pulmonary/
extrapulmonary, throat culture, tuberculin skin 
test
MDR-TB (is included 
in outcome as non-
successful treatment)
Drug regimen Rifampicin, isoniazid, ethambutol, streptomycin, 
pyrazinamide, ethionamide, other drugs
Not all covariates included under one of the constructs in the directed acyclic graph (DAG) were included in the propensity score model. 
Table 1 summarises which covariates were included and which were excluded. Some covariates that might reasonably be part of the 
pathways encoded in this DAG were excluded as there was no adequate measure of them in these linked administrative data. Other 
covariates were excluded by the missing data threshold, which itself was chosen to balance measurability of each of the constructs with the 
loss of sample size from undertaking a complete case analysis.
The housing quality node was not included in the model as it was not associated with outcome (TB mortality) or exposure. The housing node 
included measurable covariates of roof, floor, and wall material, number of people in the home, and the number of bedrooms and bathrooms, 
as well as the unmeasurable covariate of indoor air pollution.
MDR-TB, multidrug-resistant tuberculosis; TB, tuberculosis.
association with the outcome given exposure, to improve 
precision or (B) both association with exposure and 
conditional association with outcome given exposure, to 
account for confounding.23 These criteria apply to both 
mediators and confounders and can be determined from 
the DAG (figure 1). All DAG nodes meet these criteria 
but housing and thus the covariates used to model the 
propensity score were all non-housing covariates meeting 
the missing data threshold. Quadratic forms of the 
continuous covariates were used in the logistic regression 
but sensitivity analyses were performed without including 
them. Two-way interactions between gender and all vari-
ables and age and all variables were also used, given it is 
likely that these covariates would differ in effect across 
strata.
Each patient who did not receive BFP (ie, not exposed) 
was matched to a patient who did receive it (ie, exposed) 
closest in propensity score, within a particular ‘caliper' 
of 0.1 SD from the mean propensity score. Matching was 
done with replacement and multiple matches to mini-
mise both bias and variance, following Caliendo and 
Kopeinig.24 Multiple matches were weighted to form one 
matched control for each patient. Standardised mean 
differences and overlap plots were examined to assess 
whether balance was improved by matching.
Throughout the literature, complete cases are used for 
propensity score matching, and this is the approach used 
in this paper.24 This reduced the data set to 2167 individ-
uals at the 50% missing data threshold and 3048 individ-
uals at the 25% threshold.
estimating the impact of bolsa Familia
Taking the difference of the proportion of treatment 
success between matched groups resulted in an estimate 
of the average effect of treatment on the treated (ATT), 
or the (causal) risk difference in the exposed. The proce-
dure used in Abadie and Imbens25 was used to estimate 
the SE of the ATT and thus the CIs. The CIs thus account 
for the uncertainty due to the matching procedure, but 
do not account for the uncertainty due to the fact that the 
estimated propensity score is itself a function of the data; 
this latter feature leads to conservative inferences.25 The 
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Figure 2 Standardised mean difference (SMD). The change in SMD in the matched and unmatched groups for each variable. 
A smaller difference indicates improved balance between groups; being below the threshold of 0.1 is conservatively considered 
to be effectively balanced. Balance has been largely improved by matching though some imbalance remains between groups. 
bacilo.i, initial sputum smear; disorder, any other chronic illness; est, streptomycin; eta, ethambutol; eti, ethionamide; exp, 
expenditure; iso, isoniazid; mental, mental disorder; pir, pyrazinamide; rif, rifampicin; thorax, chest X-ray; throat, throat culture; 
tst, tuberculin skin test.
ATT was also estimated by a multiple imputation-based 
sensitivity analysis, and point estimates from this are 
provided for comparative purposes in online supplemen-
tary appendix 2.
statistical software
All analyses were conducted in R V.3.4.1 and the MatchIt 
package was used for the propensity score matching 
procedure.
resulTs
Propensity score matching: covariate balance
A complete balance table is presented in table 1 in online 
supplementary appendix 1 for the match produced by 
model A for all covariates included in the propensity 
score matching exercise. There is good similarity of 
the covariates after matching, suggesting a reasonable 
balance was obtained between groups. Prior to matching, 
there were some imbalances found between BFP recipi-
ents and non-recipients on important covariates. Figure 2 
presents the changes in standardised mean difference 
between those receiving BFP (ie, exposed) and those 
not receiving BFP (ie, not exposed) before and after 
matching. Figure 3 presents overlap plots to demonstrate 
the similarity of the propensity score values between 
groups.
Propensity score matching in general resulted in 
improved balance of the values of covariates between cases 
and controls. A standardised mean difference of below 
0.1 implies that groups do not differ greatly between 
values of the covariate.23 Though the matching process 
only brought 50% of the imbalanced variables below this 
threshold, a large improvement was seen on the balance 
of important upstream covariates like age (0.42 to 0.01), 
income (0.40 to 0.09) and schooling (0.24 to 0.12). The 
change in distributions of these variables after matching 
can be seen in figure 3. On average, those receiving BFP in 
the unmatched cohort were younger (34.5 vs 41.3 years), 
poorer (R$65.2 vs R$197.4 per month) and less educated 
(89.2% vs 83.5% not completed secondary school).
From figure 3, up 20.9% of patients with TB fall under 
the R$70 income threshold for unconditional receipt 
of BFP and therefore are theoretically eligible for the 
programme, but yet excluded from it. A further 29.4% 
fall under the R$140 income threshold and could there-
fore potentially be eligible for BFP.
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Figure 3 Overlap in estimated propensity scores between those receiving and those not receiving Bolsa Família Programme 
(BFP) before matching (top left) and after matching (top right). Overlap has been substantially improved by matching to treated 
(exposed) patients, suggestive of the groups being balanced on the propensity score. The region of overlap extends between 
0 and 1. Also presented are similar plots of variable distribution before and after matching for income, age and schooling (from 
top to bottom). Dotted lines on the income distributions mark the thresholds for BFP eligibility.
estimating the impact of bolsa Familia
In total, four estimates of the ATT were produced 
(table 2). Model A is the primary model of interest as 
it is the most complex model specification. Models B–D 
represent sensitivity analyses on model A to investigate 
how sensitive the results are to simplifying changes to 
these modelling and missing data decisions.
The ATT from model A was estimated to be 10.58 (95% 
CI 4.39 to 16.77) (table 2). Thus, among patients with 
TB who receive BFP, we expect a treatment success rate 
of 10.58 percentage points higher than if those patients 
had not received the benefit. The proportion success-
fully treated in those who did not receive BFP was 76.6% 
compared with 87.2% in the BFP recipients. This average 
treatment effect is protective even when a simpler model 
is used and when the missing data threshold at which 
covariates are omitted is reduced to 25%, with ATT esti-
mates between 6.31 and 7.21 (table 2). It is also in broad 
agreement with an ATT point estimate of 7.22 obtained 
from a multiple imputation approach (online supple-
mentary appendix 2). Expressed as number needed to 
treat, the estimated ATT implies that on average, among 
patients with TB who received Bolsa Familia before 
acquiring TB, one unsuccessful treatment outcome was 
averted because of Bolsa Familia for every nine patients.
dIsCussIon
summary: interpretation of results
This is the first study that uses a quasi-experimental 
approach to estimate the impact of a conditional cash 
transfer programme on TB treatment success rates.9 
Across all models, results have shown a substantial abso-
lute increase in TB treatment success rate (between 7% 
and 11%) among those who receive BFP. This seems 
to suggest a consistent positive association between 
receiving BFP on a key indicator of TB control: treatment 
success rate. This is in line with the studies of Torrens et 
al8 and Durovni et al15 and a few other previous studies 
evaluating the relationship between social protection 
and TB outcomes undertaken using less rigorous meth-
odologies and adjusting for only a subset of potential 
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Table 2 Results of propensity score matching estimates of the ATT for four models
Models*
n controls=898
n exposed=1269 ATT 95% CI
Controls matched 
(unweighted), n
Exposed 
dropped, n
Pairs matched 
(weighted), n
Unique 
controls, n
Model A† 10.58 (4.39 to 16.77) 6021 109 1160 545
Model B‡ 7.21 (1.33 to 13.09) 6468 21 1248 656 (D2)
Models*
n 
controls=1319
n 
exposed=1729 ATT 95% CI
Controls matched 
(unweighted), n
Exposed 
dropped, n
Pairs matched 
(weighted), n
Unique 
controls, n
Model C* 6.31 (1.46 to 11.16) 8895 70 1659 955
Model D*‡ 7.06 (2.57 to 11.56) 9272 17 1712 1001
The matching used was many-to-one with replacement. Some exposed patients were not similar enough to any control patients according 
to the calliper threshold and these individuals were dropped from the analysis (exposed dropped). Some controls were not similar enough to 
any exposed patients and were thus not used as potential matches and dropped from the analysis. The remaining controls (unique controls) 
were then ‘copied’ a number of times to be used as potential matches (controls matched unweighted). Each control was not matched 
individually, but rather weighted to form one matched comparator for each treatment patient. These matched comparator patients were 
matched to the treatment patients to form matched pairs (pairs of controls and treated cases matched). The number of pairs may thus be 
higher than the total initial sample size as some controls were used more than once and some were not used at all.
*Models C and D omit variables with >25% missing data.
†Model A includes linear and quadratic forms of continuous covariates and omits variables with >50% missing data to estimate the 
propensity score. Variables included in the final propensity score are those listed in bold in the caption to figure 1.
‡Models B and D omit quadratic forms of continuous covariates.
ATT, average effect of treatment on the treated.
confounders, which also demonstrate a protective effect 
of similar scale.13 26 Given the already relatively high treat-
ment success rate in Brazil, it can be expected that the 
size of impact may be even higher in settings within and 
outside Brazil, with lower treatment success rates and a 
less effective TB control programme. Similar propensity 
score approaches have already been used to evaluate the 
effect of cash transfers in HIV/AIDS, but not on TB.27
Another important and somewhat unexpected finding 
of our analysis is that the profile of patients with TB 
enrolled in BFP was not overtly dissimilar from patients 
with TB who have not received BFP even before matching. 
Figure 2 suggests that the most imbalanced covariates for 
receipt of BFP (based on the standardised mean differ-
ence) were state of residence, income, age and schooling. 
There may also be differences between recipients and 
non-recipients based on measures of the infrastructure of 
the local area (sewage, electricity, trash disposal). Patients 
with TB not benefiting from BFP transfers appear to be 
broadly similar to patients with TB who are BFP recipi-
ents under a number of other sociodemographic char-
acteristics, particularly on comorbidities such as diabetes 
and alcohol abuse, as well as on DOT prevalence table 2 
in online supplementary appendix 1. This suggests there 
may be some shared vulnerability among patients with 
TB (ie, concomitant socioeconomic stressors, diverse 
ability to navigate complex social services), who are not 
captured by the current BFP targeting and enrolment 
process, leading to some degree of disparity in access 
to social protection and specifically BFP in Brazil. Even 
when looking strictly to the BFP eligibility criterion (ie, 
income), our results show that up to 51.3% of patients 
may be theoretically eligible for BFP, but yet left out. This 
seems to further suggest that the income threshold for 
BFP is insufficiently specific to ensure access to vulner-
able patients with TB.
sTrengTH And lIMITATIons
The utilisation of quasi-experimental approach is a major 
strength of this paper. Quasi-experimental approaches 
like propensity score matching require fewer assump-
tions about the data than traditional parametric coun-
terparts. The specification of the estimand and popu-
lation parameters of interest are an additional strength 
to using propensity score matching, and the risk of bias 
from residual confounding is minimised compared with 
prior work by careful use of a DAG.28 While the use of 
propensity scores for matching has recently drawn some 
criticism,29 the diagnostic plots demonstrated in figures 2 
and 3 show that balance was improved by matching, and a 
number of model specifications for the propensity score 
were tested and found to demonstrate a similar positive 
impact.
Indeed, a clear strength of this work is the comparability 
of the control group. As demonstrated in figure 3, those 
in the exposed group and those in the control group 
have a very similar distribution of propensity to receive 
BFP. This overlap suggests that we are only comparing 
patients with similar covariate profiles: while some of the 
control patients may not be eligible on paper for BFP, 
in the complex context of real-world receipt of BFP, 
the not-exposed group (our ‘control’ group) resemble 
almost exactly those patients with TB who receive BFP on 
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all measured variables and are representative of a broad 
range of patients with TB from across Brazil. This is a 
methodological improvement over the control groups 
seen in prior work which greatly strengthens the quality 
of evidence available to policymakers.
The control group in the study of Durovni et al15 was 
taken from a pool of all patients with TB rather than 
those who are registered in CadÚnico, and therefore 
some patients ineligible for BFP were included in the 
control group. The control group in the study of Torrens 
et al8 was taken from patients with TB who were eligible 
in theory for BFP, but who had not received any money 
from the programme until after treatment. This control 
group had characteristics different from those patients 
with TB not eligible for the programme on demographic 
and socioeconomic variables examined by the authors. 
Both of these control groups may have potentially biased 
the resulting estimate of proportion of patients cured 
attributable to BFP.
This quasi-experimental approach also implies the 
possibility of drawing causal conclusions. The estimand 
used in this study, the average treatment effect on the 
treated, could be given a causal interpretation if partic-
ular ‘identifying’ assumptions hold, including: (1) posi-
tivity, which implies that no individual has a probability 
of 1 of receiving BFP conditional on their confounders; 
(2) consistency, which implies that different variations 
of receiving BFP do not have different effects on TB 
outcomes; and (3) conditional exchangeability, which 
implies that there is no residual confounding. We note 
that while BFP might appear to create a structural viola-
tion of the positivity assumption with its income threshold, 
examining the threshold itself it was noted that the cut-off 
was often inaccurately applied and thus very few random 
positivity violations were encountered in the matched 
set. With regard to the consistency assumption, we specif-
ically assumed that receipt of any amount of transfer for 
any amount of time was sufficient in this context, but 
further work should investigate dose–response relation-
ships between cash transfers and TB. Drawing causal 
conclusions is however hampered by the non-interfer-
ence assumption, which in this context assumes that the 
exposure received by one individual does not affect the 
outcome of the other. The results of this study suggest 
that the size of effect found may be too large to ignore 
this assumption and work should be undertaken to inves-
tigate the effect of social protection on TB transmission. 
Another potential violation of this assumption is that BFP 
increases the probability of treatment success in recipi-
ents and in other cases through community effects of the 
cash transfer.
In conclusion, while most identifying assumptions are 
potentially plausible, we cannot draw conclusions about 
causality given the interference limitations outlined 
above. The circumstances under which causal inferences 
can be drawn with interference is an area of ongoing 
research.30
Another limitation to this work is the data quality. The 
missing data results in a relatively small sample size used 
for matching and we cannot rule out the possibility of 
residual confounding from covariates that are mostly 
missing or remain unbalanced. Remaining imbalance on 
the state variable suggests data may be missing condition-
ally at random on the state variable. As information on 
it is housed within a separate register, we were unable to 
assess the impact of the Family Health Strategy, (FHS) 
though previous work suggests the effect of BFP is inde-
pendent of Family Health Strategy (FHS) coverage.15 
While an approach combining multiple imputation and 
propensity score matching would have mitigated this 
problem, there remain many gaps in the literature on the 
practical implementation of these techniques together 
(see online supplementary appendix 2). Furthermore, 
the data linkage is cross-sectional and thus time-varying 
confounding cannot be accounted for with these data; 
better data availability longitudinally would allow for 
measurement on more direct measures of TB control, 
such as incidence.
The choice of a dichotomous outcome variable may 
be another limitation: non-success outcomes include 
continued disease after regimen completion, treatment 
abandonment, death from TB, death from other causes 
and development of multidrug-resistant TB, which may 
have heterogeneous risk factors. Loss to follow-up and 
transferred cases are also not considered by this anal-
ysis—the analysis is agnostic about whether these patients 
were cured or not cured. The results may be different if 
each non-success outcome were addressed in turn, but 
this would require a larger sample size and may be best 
addressed in a descriptive study.
Policy implications
Despite the above limitations, these findings prelimi-
narily suggest that: (1) there is a considerable proportion 
of patients with TB eligible for BFP that for unknown 
reasons seem to be left out from the programme; (2) 
almost half of the patients with TB will not be eligible 
for BFP according to income thresholds, and thus there 
is room for a more comprehensive or multidimensional 
targeting approach not only using income as eligibility 
criteria. Given the 7%–11% absolute increase in treat-
ment success rate seen among those receiving BFP from 
our work, from a health rights perspective, it must be 
considered how best to deliver a protective programme 
to vulnerable patients in Brazil.
BFP was not designed to address specific diseases, 
not least TB: TB status is not a targeting criterion and 
none of the conditionalities currently imposed by the 
programme have any direct implication for TB care and/
or TB control. Despite the suggested positive impact, 
ethical and equity issues make unlikely that TB will 
become one of the eligibility criteria of BFP. Nonetheless, 
access could be expanded, and thus impact maximised, 
by making BFP more TB sensitive through a more inclu-
sive, although non-stigmatising, targeting strategy. Higher 
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impact could in fact be achieved by simply ensuring that 
patients who are already eligible by definition for the 
programme receive the benefits, or at least receive them 
while on treatment. To this purpose, further research is 
urgently needed to understand determinants of access to 
BFP from patients with TB and to explore those supply 
and demand side barriers that delay the transfer of bene-
fits once patients with TB are legitimately enrolled.
Understanding how to effectively and cost-effectively 
remove these individual and system-level barriers and 
what may be the ultimate impact on the Brazilian TB 
epidemic is a priority research area, whose lessons may 
be transferrable to other settings.
Nonetheless, it can be anticipated that the removal of 
these barriers may require the implementation of more 
efficient BFP delivery models, including the ‘single 
window’ approach which entails an integrated delivery 
of TB care services and social protection.31 According 
to this model, the access to the most appropriate social 
protection schemes is determined and facilitated at the 
primary healthcare level where ad hoc staff (eg, social 
workers) are trained to assess the social protection needs 
of patients with TB and provide information, legal and 
administrative advices, and referrals to various services 
so to allow patients to access benefits from one ‘single 
window’ without having to navigate across complex and 
multiple service points.31
Another emerging model for the delivery of social 
protection is the ‘cash plus’ model in which the provi-
sion of cash transfers is combined with another form of 
social support when the provision of in-kind benefits is 
not deemed sufficient to reduce households’ vulnerabili-
ties (including health-related vulnerabilities).32
In the case of TB in Brazil, this ‘plus’ component can be 
represented by a top-up of the cash benefit to account for 
the TB-related catastrophic costs incurred by the house-
holds; or the provision of a food basket to improve nutri-
tion of cash beneficiaries and therefore their treatment 
outcome; or the improvement of housing and ventilation 
conditions to interrupt intrahousehold transmission of 
TB. To identify the most relevant ‘intensifier’ of any cash 
transfer intervention it will be essential also to under-
stand thoroughly the most likely pathway through which 
this impact takes place. This requires the development 
of a setting-specific, epidemiologically driven conceptual 
framework and a more comprehensive collection of data 
for the variables in the causal pathway.
To be useful the above research agenda should rely on 
both quantitative and qualitative methods to embrace the 
complexity of pathways likely to underlie impact and the 
multifaced nature of determinants of access to cash trans-
fers in the context of TB-affected communities.
ConClusIons
Overall, the strength of evidence and size of effect of 
the ATT estimated in this work seems to suggest that 
expanding social protection to a wider population of 
patients with TB may represent a valid mechanism for 
improving TB outcomes beyond the traditional biomed-
ical approach. This is consistent with the need of a multi-
sectoral accountability framework expressed during the 
last WHO-Global Ministerial Conference held in Moscow 
in November 2017 which demands a more pervasive inte-
gration of TB programmatic action within development 
models and infrastructures.33 It is essential that, like in this 
work, recent developments in quasi-experimental meth-
odology continue to be integrated with the evidence base 
for bold policies in development. With stronger evidence 
available, the rapid implementation of bold policies may 
be justified in TB contexts and the global public health 
community will be a large step closer to achieving the 
aims of the WHO’s End TB Strategy.
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